Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anthracycline vs nonanthracycline adjuvant therapy for breast cancer.
Tack DK, Palmieri FM, Perez EA. Tack DK, et al. Among authors: palmieri fm. Oncology (Williston Park). 2004 Oct;18(11):1367-76; discussion 1378, 1381. Oncology (Williston Park). 2004. PMID: 15609467 Review.
Adjuvant trastuzumab for HER2-positive early breast cancer.
Palmieri FM, Myatt CV, Perez EA. Palmieri FM, et al. Clin J Oncol Nurs. 2010 Jun;14(3):326-36. doi: 10.1188/10.CJON.326-336. Clin J Oncol Nurs. 2010. PMID: 20529794 Review.
Trastuzumab.
Perez EA, Palmieri FM, Brock SM. Perez EA, et al. Among authors: palmieri fm. Cancer Treat Res. 2009;151:181-96. doi: 10.1007/978-0-387-75115-3_12. Cancer Treat Res. 2009. PMID: 19593513 Review. No abstract available.
Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status.
Amar S, McCullough AE, Tan W, Geiger XJ, Boughey JC, McNeil RB, Coppola KE, McLaughlin SA, Palmieri FM, Perez EA. Amar S, et al. Among authors: palmieri fm. Oncologist. 2010;15(10):1043-9. doi: 10.1634/theoncologist.2010-0036. Epub 2010 Oct 7. Oncologist. 2010. PMID: 20930097 Free PMC article.
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.
Moreno-Aspitia A, Dueck AC, Ghanem-Cañete I, Patel T, Dakhil S, Johnson D, Franco S, Kahanic S, Colon-Otero G, Tenner KS, Rodeheffer R, McCullough AE, Jenkins RB, Palmieri FM, Northfelt D, Perez EA. Moreno-Aspitia A, et al. Among authors: palmieri fm. Breast Cancer Res Treat. 2013 Apr;138(2):427-35. doi: 10.1007/s10549-013-2469-2. Epub 2013 Mar 12. Breast Cancer Res Treat. 2013. PMID: 23479422 Free PMC article. Clinical Trial.
Challenges of oral medications in patients with advanced breast cancer.
Palmieri FM, Barton DL. Palmieri FM, et al. Semin Oncol Nurs. 2007 Nov;23(4 Suppl 2):S17-22. doi: 10.1016/j.soncn.2007.10.004. Semin Oncol Nurs. 2007. PMID: 18054678 Review.
Managing high-risk breast cancer.
Palmieri FM, Perez EA. Palmieri FM, et al. Semin Oncol Nurs. 2007 Feb;23(1):29-36. doi: 10.1016/j.soncn.2006.11.005. Semin Oncol Nurs. 2007. PMID: 17303514 Free PMC article. Review.
Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer.
Eniu A, Palmieri FM, Perez EA. Eniu A, et al. Among authors: palmieri fm. Oncologist. 2005 Oct;10(9):665-85. doi: 10.1634/theoncologist.10-9-665. Oncologist. 2005. PMID: 16249346 Review.
Adjuvant therapy for breast cancer: recommendations for management based on consensus review and recent clinical trials.
Mincey BA, Palmieri FM, Perez EA. Mincey BA, et al. Among authors: palmieri fm. Oncologist. 2002;7(3):246-50. doi: 10.1634/theoncologist.7-3-246. Oncologist. 2002. PMID: 12065798 Review.
Recent advances in adjuvant therapy for breast cancer.
Palmieri FM, Perez EA. Palmieri FM, et al. Semin Oncol Nurs. 2003 Nov;19(4 Suppl 2):10-6. doi: 10.1053/j.soncn.2003.09.004. Semin Oncol Nurs. 2003. PMID: 14702916 Review.
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback